Corporate Restructuring and Competition in Pharma - Pharmaceutical giant Novo Nordisk (NVO) announced a significant restructuring that includes cutting 9,000 jobs globally, approximately 11.5% of its total workforce, in response to intense competition from Eli Lilly (LLY) in the weight-loss drug market [4][8] - The restructuring aims to save 8 billion Danish kroner (approximately $1.25 billion) annually by 2026, with 5,000 positions being cut in Denmark to streamline operations and refocus resources on core growth areas [4][8] Market Overview - Global equity markets demonstrated robust performance, with the S&P 500 concluding the day at a record level, and the Nikkei Share Average in Japan reaching an all-time peak, reflecting strong investor confidence [2][8] - The Australian Dollar approached its highest level in ten months ahead of the US Consumer Price Index (CPI) release, indicating market anticipation of economic data [3] - In South Korea, shares were boosted by gains in the tech and battery sectors at market open [2] Economic Indicators - The UK housing market is reportedly facing its biggest price falls in more than a year and a half, indicating potential economic headwinds in the region [12]